Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute orexin antagonism selectively modulates anticipatory anxiety in humans: implications for addiction and anxiety
Stephanie M. Gorka, Kia J. Khorrami, Charles A. Manzler, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 26
Modulation of noradrenergic signalling reverses stress-induced changes in the hippocampus: Involvement of orexinergic systems
Masoumeh Sarfi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Brain Research (2025), pp. 149491-149491
Open Access | Times Cited: 1
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Harry Fagan, David S. Baldwin
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 6, pp. 535-548
Open Access | Times Cited: 22
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 21
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 16
Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair
Danlei Liu, Xuefeng Zheng, Yuqing Hui, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Intolerance of Uncertainty and Its Association With Cancer-Related Symptoms
Yesol Yang, Yu‐Fen Lin, Bohyun Kim, et al.
Cancer Nursing (2025)
Closed Access
Trait state occasion (TSO) modeling of event-related potentials (ERPs)
Brent I. Rappaport, Anna Weinberg, James E. Glazer, et al.
Biological Psychology (2025), pp. 109000-109000
Closed Access
Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access
Insomnia and the Orexinergic Pathway in the Link with Psychopathology: Effects of DORAs in Insomnia Comorbid with Mental Disturbances
Laura Palagini, Pierre A. Geoffroy, Gaspare Alfì, et al.
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 119-131
Closed Access | Times Cited: 3
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 2
Embryonic ethanol exposure and optogenetic activation of hypocretin neurons stimulate similar behaviors early in life associated with later alcohol consumption
Adam D. Collier, Nushrat Yasmin, Olga Karatayev, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
Hye Ji J. Kim, Ayat Zagzoog, Costanza Ceni, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 314-314
Open Access | Times Cited: 4
Sex-Specific Roles of Hypocretin Receptor Signaling in CRF Neurons on Alcohol Drinking, Anxiety, and BNST Neuronal Excitability
Yihe Ma, Haniyyah Sardar, Max E. Benabou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
Giorgio Bergamini, Preciosa Coloma, Helene Massinet, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4
Anxiolytic-like effects of the dual orexin receptor antagonist daridorexant in rats
Michel A. Steiner, R Locher, Hugues Lecourt, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104056-104056
Open Access
Modulation of noradrenergic signalling reverses stress-induced changes in the hippocampus: involvement of orexinergic systems
Masoumeh Sarfi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Research Square (Research Square) (2024)
Closed Access
Anxiolytic-like effects of the dual orexin receptor antagonist daridorexant in rats
R Locher, Hugues Lecourt, François Jenck, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top